{"id":"W2082207901","doi":"10.1002/ijc.24884","title":"The effects of gefitinib in tamoxifen‐resistant and hormone‐insensitive breast cancer: A phase II study","year":2009,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; World Health Organization","keywords":"Gefitinib; Tamoxifen; Breast cancer; Medicine; Epidermal growth factor receptor; Internal medicine; Estrogen receptor; Oncology; EGFR inhibitors; Cancer; Cancer research; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001441035,0.001683593,0.002858356,0.0004995727,0.0003675761,0.0006796158,0.0007124093,0.001202277,0.00161837],"category_scores_gemma":[0.0006727785,0.0005555032,0.001256221,0.0003783415,0.0006858792,0.0006962888,0.0002174424,0.001933408,0.0004840354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006417873,"about_ca_system_score_gemma":0.0008003886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006672878,"about_ca_topic_score_gemma":0.002251358,"domain_scores_codex":[0.9994796,0.0002586303,0.00003140242,0.00007070209,0.00004959715,0.0001100432],"domain_scores_gemma":[0.999416,0.0001018166,0.0001077871,0.00007097497,0.00003415997,0.0002692154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5804806,0.119596,0.01207196,0.001016062,0.001886186,0.0008163463,0.0005013414,0.002895941,0.1726573,0.0002439792,0.00274099,0.1050933],"study_design_scores_gemma":[0.2898499,0.6597603,0.03568523,0.00003273783,0.0005975944,0.0009486079,0.0001113114,0.001443273,0.009330567,0.0001182461,0.002060946,0.0000612947],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967389,0.001700676,0.0002178035,0.00009879054,0.00004350668,0.0005141848,0.0002580033,0.00003713843,0.0003911777],"genre_scores_gemma":[0.9930488,0.001980407,0.0006858255,0.0003094171,0.0001185723,0.001136046,0.001368475,0.0000247568,0.001327623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002858356,"threshold_uncertainty_score":0.00762099,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01451596220724158,"score_gpt":0.4154056267011625,"score_spread":0.4008896644939209,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}